Kura Oncology (KURA) Long-Term Debt Issuances (2010 - 2015)

Kura Oncology's (KURA) quarterly Long-Term Debt Issuances came in at -$3.6 million in Q2 2015, down 183.45% on a QoQ basis from $4.3 million in Q1 2015.

Kura Oncology (KURA) Long-Term Debt Issuances (2010 - 2015) Analysis & Trends

Kura Oncology (KURA) has 5 years of Long-Term Debt Issuances data on file, last reported at -$3.6 million in Q2 2015.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to -$3.6 million in Q2 2015; TTM through Sep 2016 was -$3.6 million, a 232.1% decrease from a year earlier, with the FY2022 full-year figure at $10.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q2 2015 stood at -$3.6 million, down from $4.3 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for KURA reached as high as $4.3 million in Q1 2015 and fell as low as -$3.6 million in Q2 2015.
  • Historically, Long-Term Debt Issuances has averaged $476666.7 across 4 years, with a median of $62500.0 in 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Kura Oncology 925.97 Mn 925.97 Mn 18.00 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2015 -3.58 Mn
Jun 30, 2015 -3.58 Mn
Mar 31, 2015 4.29 Mn
Mar 31, 2015 4.29 Mn
Dec 31, 2014 2.00 Mn
Dec 31, 2014 2.00 Mn
Sep 30, 2014 100,000.00
Sep 30, 2014 100,000.00
Jun 30, 2013 25,000.00
Jun 30, 2013 25,000.00
Mar 31, 2012 25,000.00
Mar 31, 2012 25,000.00
Dec 31, 2010 35,000.00
Dec 31, 2010 35,000.00